Clinical Trial Update: SU5416 and Carboplatin to Treat Ovarian Cancer [Phase 1]

View source ↗

Summary

A Phase 1 study evaluated SU5416 in combination with carboplatin for ovarian, fallopian tube, and peritoneal cancers; the trial status shows completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• SU5416 (semaxanib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Fallopian Tube Neoplasm, Ovarian Cancer | Phase 1 | Status: COMPLETED